RESUMO
PURPOSE: This study aimed to investigate whether 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor with anti-inflammatory effects, could alleviate spontaneous recurrent seizures (SRS) and epilepsy-associated depressive behaviours in the lithium chloride (LiCl)-pilocarpine-induced post-status epilepticus (SE) rat model. METHODS: The rats were intraperitoneally (IP) injected with LiCl (127â¯mg/kg) and pilocarpine (40â¯mg/kg) to induce SE. A video surveillance system was used to monitor SRS in the post-SE model for 6â¯weeks (from the onset of the 2nd week to the end of the 7th week after SE induction). TPPU (0.1â¯mg/kg/d) was intragastrically given for 4â¯weeks from the 21st day after SE induction in the SRSâ¯+â¯0.1 TPPU group. The SRSâ¯+â¯PEG 400 group was given the vehicle (40% polyethylene glycol 400) instead, and the control group was given LiCl and PEG 400 but not pilocarpine. The sucrose preference test (SPT) and forced swim test (FST) were conducted to evaluate the depression-like behaviours of rats. Immunofluorescent staining, enzyme-linked immunosorbent assay, and western blot analysis were performed to measure astrocytic and microglial gliosis, neuronal loss, and levels of soluble epoxide hydrolase (sEH), cytokines [tumour necrosis factor alpha (TNF-α), interleukin (IL)-1ß, and IL-6], and cyclic adenosine monophosphate (cAMP)-response element binding protein (CREB). RESULTS: The frequency of SRS was significantly decreased at 6â¯weeks and 7â¯weeks after SE induction in the 0.1TPP U group compared with the SRSâ¯+â¯PEG 400 group. The immobility time (IMT) evaluated by FST was significantly decreased, whereas the climbing time (CMT) was increased, and the sucrose preference rate (SPR) evaluated by SPT was in an increasing trend. The levels of sEH, TNF-α, IL-1ß, and IL-6 in the hippocampus (Hip) and prefrontal cortex (PFC) were all significantly increased in the SRSâ¯+â¯PEG 400 group compared with the control group; neuronal loss, astrogliosis, and microglial activation were also observed. The astrocytic and microglial activation and levels of the pro-inflammatory cytokines in the Hip and PFC were significantly attenuated in the TPPU group compared with the SRSâ¯+â¯PEG 400 group; moreover, neuronal loss and the decreased CREB expression were significantly alleviated as well. CONCLUSION: TPPU treatment after SE attenuates SRS and epilepsy-associated depressive behaviours in the LiCl-pilocarpine induced post-SE rat model, and it also exerts anti-inflammatory effects in the brain. Our findings suggest a new therapeutic approach for epilepsy and its comorbidities, especially depression.
Assuntos
Compostos de Fenilureia/farmacologia , Piperidinas/farmacologia , Convulsões/tratamento farmacológico , Animais , Astrócitos/metabolismo , Encéfalo/metabolismo , Depressão/tratamento farmacológico , Transtorno Depressivo/metabolismo , Modelos Animais de Doenças , Epilepsia/induzido quimicamente , Epilepsia/tratamento farmacológico , Epóxido Hidrolases/metabolismo , Hipocampo/metabolismo , Cloreto de Lítio/farmacologia , Masculino , Microglia/metabolismo , Neurônios/metabolismo , Pilocarpina/farmacologia , Ratos , Ratos Sprague-Dawley , Convulsões/metabolismo , Estado Epiléptico , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Purpose: Valproate (VPA) resistance was reported to be an important predictor of intractable epilepsy. We conducted this study to identify candidate biomarkers in peripheral blood correlated with VPA resistance. Methods: The microarray dataset (GSE143272) was downloaded from the Gene Expression Omnibus database. Weighted gene co-expression network analysis (WGCNA) was performed to construct co-expression modules and obtain the most prominent module associated with VPA resistance. Differentially expressed genes (DEGs) between VPA-responsive and VPA-resistant patients were obtained using the "Limma" package in R. The intersections between the most prominent module and DEGs were identified as target genes. Metascape was performed to discover the possible involved pathways of the target genes. GeneCards database was used to know the function of each target gene. Results: All genes in the GSE143272 were divided into 24 different modules. Among these modules, the darkred module showed a pivotal correlation with VPA resistance. A total of 70 DEGs between VPA-responsive and VPA-resistant patients were identified. After taking the intersection, 25 target genes were obtained. The 25 target genes were significantly enriched in T cell receptor recognition, T cell receptor signaling pathway, regulation of T cell activation, cytokine-cytokine receptor interaction, and in utero embryonic development. Half of the target genes (CD3D, CD3G, CXCR3, CXCR6, GATA3, GZMK, IL7R, LIME1, SIRPG, THEMIS, TRAT1, and ZNF683) were directly involved in the T cell development, migration, and activation signaling pathway. Conclusion: We identified 25 target genes prominently associated with VPA resistance, which could be potential candidate biomarkers for epilepsy resistance in peripheral blood. The peripheral blood T cells may play a crucial role in VPA resistance. Those genes and pathways might become therapeutic targets with clinical usefulness in the future.
RESUMO
Plasmonic photocatalysts with hollow structures and tunable composition exhibit significant advantages due to their high efficiency in light collection and effective charge transfer across the tight contact heterojunction interface. Herein, hollow Ag/AgCl microcubes were developed by treating nanosheet-assembled hollow Ag microcubes with FeCl3, where a part of Ag at the interface could be in situ transformed and oxidized into AgCl. Equally, by adjusting the concentration of Fe3+ ions, Ag/AgCl hollow microcubes with different compositions could be easily achieved. Electron transfer was favored by a lot of tiny Ag/AgCl heterojunctions induced by the in situ oxidation of the multicrystalline Ag hollow microcube template containing a number of grain boundaries. The designed hollow Ag/AgCl microcubes exhibited strong visible-light adsorption owing to the surface plasmon resonance effect of Ag nanoparticles, in addition to the multiple light-reflections inside the hollow structure. The as-obtained products were then used as visible-light photocatalysts, where the results indicated that 91.6% of phenol was degraded within 150 min under visible light by the as-obtained sample with a Ag to AgCl ratio of 1 : 3. The superior visible-light photocatalytic activity resulted from the enhancement of the visible light-harvesting and the efficient charge separation at the Ag and AgCl contact interfaces.
RESUMO
AIMS: To identify transcriptome signatures underlying epileptogenesis in temporal lobe epilepsy (TLE). METHODS: Robust rank aggregation analysis was used to integrate multiple microarrays in rodent models of TLE and determine differentially expressed genes (DEGs) in acute, latent, and chronic stages. Functional annotation and protein-protein interaction analysis were performed to explore the potential functions of the DEGs and identify hub genes with the highest intramodular connectivity. The association between hub genes and hippocampal sclerosis/seizure frequency was analyzed using publicly available RNA-sequencing datasets from TLE patients. We subsequently established a pilocarpine-induced status epilepticus (SE) model in rats and validated mRNA expression of hub genes by quantitative reverse transcription PCR (qRT-PCR). RESULTS: The DEGs in the acute, latent, and chronic phases of TLE in animal models were prominently enriched in inflammatory response. Hub genes identified in the acute phase mainly participated in biological processes including inflammation, blood-brain barrier damage, and cell adhesion. The hub genes in the latent phase were related to microglia/macrophage activation (Emr1 and Aif1) and phagocytosis (Cd68, Tyrobp, and Lyz). In the chronic phase, the hub genes were associated with activation of complements and microglia/macrophages. We further found that some hub genes identified in human TLE, such as Tlr2, Lgals3, and Stat3, were positively correlated with seizure frequency. Other hub genes, including Lgals3 and Serpine1, were associated with hippocampus sclerosis. qRT-PCR analysis confirmed that the mRNA levels of hub genes in rat hippocampus were significantly up-regulated after SE induction. CONCLUSIONS: Our integrated analysis identified hub genes in different stages of epilepsy. The functional annotations suggest that the activation and phagocytic activities of microglia/macrophages may play critical roles in epileptogenesis of TLE.
Assuntos
Biologia Computacional/métodos , Epilepsia do Lobo Temporal/genética , Epilepsia do Lobo Temporal/fisiopatologia , Mapas de Interação de Proteínas/fisiologia , Transcriptoma/fisiologia , Animais , Epilepsia do Lobo Temporal/induzido quimicamente , Humanos , Masculino , Pilocarpina/toxicidade , Mapas de Interação de Proteínas/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Transcriptoma/efeitos dos fármacosRESUMO
A known cause of seizure-induced respiratory arrest is the deficiency in serotonergic neurotransmission. Tryptophan hydroxylase-2 (TPH2) is the rate-limiting enzyme of central serotonin (5-hydroxytryptamine) synthesis which converts l-tryptophan to 5-hydroxytryptophan. A recent study revealed a reduction in TPH2 protein expression in the brainstems of DBA/1 mice that developed recurrent seizure-induced respiratory arrest, whereas the activity of this protein was unexplored. Thus this study aims to investigate the association between intrinsic 5-hydroxytryptamine synthesis in the brainstem and the susceptibility for sudden unexpected death in epilepsy in DBA/1 mice. The effect of LY393558, a potent 5-hydroxytryptamine reuptake inhibitor with 5-HT1B/1D receptor antagonist properties, on seizure-induced respiratory arrest evoked by acoustic stimulation was also examined in DBA/1 mice. ELISA results showed significantly decreased TPH2 activity in the brainstems of untreated DBA/1 mice than that of C57BL/6J mice. Moreover, the concentrations of 5-hydroxytryptamine, 5-hydroxytryptophan and 5-HIAA in the brainstems of DBA/1 mice with or without acoustic stimulation were significantly lower than that of C57BL/6J mice. Acute administration of LY393558 also significantly reduced seizure-induced respiratory arrest in DBA/1 mice. These observations provide novel evidences for the hypothesis that 5-hydroxytryptamine deficiency might be a potential cause of seizure-induced respiratory arrest.